SEC Form 4 · accession 0001652252-17-000033
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Norman D Schwartz
Officer — Chairman, President, and CEO · Director · 10% Owner
Period of report
May 23, 2017
Accepted (ET)
May 25, 2017 · 1:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad B Common Stock | May 23, 2017 | M | 37,500 | $75.00 | A | 241,468 | D | |
| Bio-Rad B Common Stock | May 23, 2017 | F | 25,605 | $216.00 | D | 215,863 | D | |
| Bio-Rad A Common Stock | holding | — | — | — | 411,252 | D | ||
| Bio-Rad B Common StockF1 | holding | — | — | — | 12,664 | I | By Spouse | |
| Bio-Rad B Common StockF2 | holding | — | — | — | 4,060,054 | I | By Blue Raven Partners, L.P. | |
| Bio-Rad B Common StockF3 | holding | — | — | — | 13,726 | I | By DANSA Partnership |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4 | $75.00 | May 23, 2017 | M | 37,500 | D | — | Aug 1, 2017 | Bio-Rad B Common Stock | 37,500 | 0 | D |
Explanation of responses
- F1The reporting person disclaims beneficial ownership of these shares.
- F2The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
- F3The shares are held by a limited partnership of which the reporting person is a limited partner.
- F4The option vested in five equal annual installments beginning on August 1, 2008.